INCY (STOCKS)
Incyte Genomics Inc
$99.000000
-1.050000 (-1.05%)
Prev close: $100.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- William J. Meury
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $19,412.22M
- Employees
- 2,617
- P/E (TTM)
- 15.42
- P/B (TTM)
- 3.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
7
Buy
15
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.80 | $1.97 | -0.1663 | -8.46% |
|
Sep 2025 (Q3)
|
$2.26 | $1.69 | +0.5702 | +33.74% |
|
Jun 2025 (Q2)
|
$1.57 | $1.50 | +0.0707 | +4.72% |
|
Mar 2025 (Q1)
|
$1.16 | $1.04 | +0.1234 | +11.90% |
Financial Statements
| Assets | $6.33B |
| Current Assets | $4.28B |
| Inventory | $83.45M |
| Other Current Assets | $4.19B |
| Noncurrent Assets | $2.05B |
| Fixed Assets | $798.63M |
| Other Non-current Assets | $1.25B |
| Liabilities | $1.68B |
| Current Liabilities | $1.34B |
| Accounts Payable | $171.93M |
| Wages | $168.25M |
| Other Current Liabilities | $998.55M |
| Noncurrent Liabilities | $340.43M |
| Equity | $4.65B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.65B |
| Liabilities And Equity | $6.33B |